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        A substantial amount of the human genome is 
subject to copy number (CN) variation (CNV); 
12% of it lies within CN-variable regions (  1  ). 
These regions contain submicroscopic segments 
of DNA, ranging in size from kilobases to mega-
bases, which may be deleted in some individuals 
but duplicated, perhaps several times, in others. 
CNV has been defi  ned as a DNA segment that 
is 1 kb or larger and is present at variable CN in 
comparison with a reference genome (  2  ). The 
implications of such widespread genetic CNV 
on phenotypic variation are as yet uncertain, but 
some CN variants are clearly associated with 
disease. CNV may directly cause disease when 
the genomic rearrangements disrupt genes vi-
tal for normal development; e.g., both micro-
deletions and microduplications at chromosome 
17p11.2 result in syndromes characterized by 
developmental delay and mental retardation (  3  ). 
CNV has also been associated with complex dis-
ease traits, e.g., susceptibility to HIV infection, 
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    Copy number (CN) variation (CNV) has been shown to be common in regions of the genome 
coding for immune-related genes, and thus impacts upon polygenic autoimmunity. Low CN 
of   FCGR3B   has recently been associated with systemic lupus erythematosus (SLE). Fc    RIIIb 
is a glycosylphosphatidylinositol-linked, low affi  nity receptor for IgG found predominantly 
on human neutrophils. We present novel data demonstrating that both in a family with 
Fc    RIIIb-defi  ciency and in the normal population,   FCGR3B   CNV correlates with protein 
expression, with neutrophil uptake of and adherence to immune complexes, and with 
soluble serum Fc    RIIIb. Reduced Fc    RIIIb expression is thus likely to contribute to the 
impaired clearance of immune complexes, which is a feature of SLE, explaining the associa-
tion between low   FCGR3B   CNV and SLE that we have confi  rmed in a Caucasian population. 
In contrast, antineutrophil cytoplasmic antibody  –  associated systemic vasculitis (AASV), a 
disease not associated with immune complex deposition, is associated with high   FCGR3B   
CN. Thus, we defi  ne a role for   FCGR3B   CNV in immune complex clearance, a function that 
may explain why low   FCGR3B   CNV is associated with SLE, but not AASV. This is the fi  rst 
report of an association between disease-related gene CNV and variation in protein ex-
pression and function that may contribute to autoimmune disease susceptibility. 1574   FCGR3B   COPY NUMBER, SYSTEMIC LUPUS ERYTHEMATOSUS, AND VASCULITIS   | Willcocks et al. 
  The function of Fc    RIIIb has been diffi   cult to elucidate, 
as there is no mouse orthologue. Studies using ligation or 
blocking of Fc    RIIIb and those removing all GPI-linked 
proteins from the neutrophil surface have often given con-
fl  icting results, which is perhaps not surprising in view of the 
diff  erent methods used. Thus, there is debate about whether 
Fc    RIIIb binds immune-complexed IgG under static (  19  ) 
or only under fl  ow (  20  ) conditions. One study suggests that 
Fc    RIIIb binding mediates phagocytosis (  21  ), whereas others 
suggest it is involved in surface binding only (  19, 22  ). Fc    RIIIb 
ligation may play a role in generation of the neutrophil re-
spiratory burst (  23  ), but, again, this is controversial (  24  ). Approx-
imately 0.1% of Europeans do not express Fc    RIIIb (  25, 26  ). 
Such Fc    RIIIb-defi  cient individuals have been described in 
the context of neonatal neutropenia (  25  ) and in a single case 
of SLE (  27  ). In contrast to antibody-blocking studies (  21  ), an in 
vitro study of cells from Fc    RIIIb-defi  cient individuals failed 
to show a functional defi  cit, leading to the suggestion that 
an increase in surface expression of Fc    RI may compensate 
(  28  ). Thus, the function of Fc    RIIIb remains poorly defi  ned, 
presumably because of nonphysiological eff  ects of the block-
ing agents used in some studies and the fact that CNV has not 
been taken into account. Further studies in Fc    RIIIb-defi  -
cient subjects are the best way to defi  ne function and resolve 
these controversies. 
  In this study, we fi  rst confi  rmed the observation that SLE 
was associated with low   FCGR3B   CN in Caucasians (  5  ), 
though we did not fi  nd such an association with SLE in a 
Chinese population. To determine the mechanism under-
lying this association, we investigated the functional eff  ects of 
  FCGR3B   CNV. Using neutrophils from an individual defi  cient 
in the receptor and from members of her family, we showed 
that   FCGR3B   CN correlates with cell surface expression, 
levels of soluble Fc    RIIIb, and neutrophil adherence to, and 
uptake of, immune complexes. We found the same relationship 
between   FCGR3B   CN, protein expression, and function ex-
ists in the general population. We then went on to investigate 
  FCGR3B   CNV in AASV. AASV is a systemic autoimmune 
disease characterized by infl  ammation and necrosis of the 
microvasculature. The pathology is mediated by Fc    R-medi-
ated activation of neutrophils rather than immune complex 
deposition as in SLE. Unlike SLE, we found that AASV was 
associated with increased   FCGR3B   CN. By demonstrating the 
functional eff  ects of reduced   FCGR3B   CN on protein ex-
pression and immune complex handling, we have provided 
an explanation for the association of low   FCGR3B   CN with 
SLE, but not with AASV. 
    RESULTS AND DISCUSSION   
  Association of low   FCGR3B   CN with SLE in a UK, 
but not Hong Kong, population 
  We sought to replicate the previously reported association be-
tween low   FCGR3B   CN and SLE (  26  ). We assessed   FCGR3B   
CN using a quantitative PCR method modifi  ed after that 
described by Fanciulli et al. (  26  ), which compares the num-
ber of cycles required for amplifi  cation of   FCGR3B   to reach 
psoriasis, and systemic lupus erythematosus (SLE), diseases in 
which multiple genetic and environmental factors play a role 
in pathogenesis (  4  –  8  ). As the number of genetic association 
studies linking CNV and common, complex disease traits 
  increases, it will be necessary to determine the eff  ect of CNV 
on both gene expression and cellular function to explain how 
CNV aff  ects disease pathogenesis. This is particularly impor-
tant in view of several potential problems with CN assays, 
which often produce results that are continuously distributed 
across the population, rather than falling into discrete   “  bins  ”   
associated with CN. Diffi   culties in CN assignation could thus 
lead to false associations (  7  ). In addition, CNV in one gene 
may be in linkage disequilibrium with CNV and/or single-
nucleotide polymorphisms in other genes, making it diffi   cult 
to determine by genetic analysis alone which variant is causal. 
Correlation of expression and function with CN assays can 
therefore help validate the CN assay itself, in addition to ex-
plaining the disease association. 
  CN variability can aff  ect gene expression: in a recent study 
by Stranger et al., CNV accounted for 18% of variation in 
gene expression in cell lines from individuals in the HapMap 
project (  9  ). Because many genes that control the immune 
system are found in CNV regions (  1  ), it is not surprising 
that CNV should determine diff  erences in immune system 
activation between individuals, and thus susceptibility to im-
mune-mediated disease. CNV in two genes in diff  erent chro-
mosomal locations (  C4   on chromosome 6 [  6  ] and   FCGR3B   
on chromosome 1 [  5  ]) have been independently associated 
with susceptibility to SLE, a complex polygenic autoimmune 
disease characterized by autoantibody production, immune 
complex deposition, and infl  ammatory damage to multiple 
organ systems. 
  Fc    RIIIb is one member of a family of low-affi   nity Fc     re-
ceptors that are widely expressed on cells of the immune system, 
binding IgG in immune-complexed rather than soluble form. 
They are encoded by a cluster of genes found on distal chromo-
some 1 and can be activatory (Fc    RIIa, Fc    RIIIa, Fc    RIIIb, 
and Fc    RIIc) or inhibitory (Fc    RIIb) (  10  ). Fc    RIIIb is found 
only in humans and is unique among this family of receptors 
in that its expression is largely restricted to neutrophils and it 
is linked to the outer leafl  et of the plasma membrane by a 
glycosylphosphatidylinositol (GPI) anchor (  11  ). It has no cyto-
plasmic domain, and therefore is thought to signal through as-
sociation with complement receptor 3 (  12  ), Fc    RIIa (  13  ), or 
lipid rafts (  14  ). Fc    RIIIb can also be released from the surface of 
neutrophils upon activation (  15  ). There are two common poly-
morphic forms of   FCGR3B   (  FCGR3B*1   and   FCGR3B*2  ), 
which diff  er by fi  ve nucleotides (141, 147, 227, 277, and 349) 
within exon 3, resulting in a 4-aa substitution in its membrane-
distal, immunoglobulin-like extracellular domain. This gives 
rise to two isoforms termed F    RIIIb-HNA1a and Fc    RIIIb-
HNA1b (previously known as NA1 and NA2, respectively) 
(  16  ). The Fc    RIIIb-HNA1b (NA2) polymorphism has been 
associated with SLE ( 17  ), whereas the Fc   RIIIb-HNA1a (NA1) 
polymorphism has been associated with antineutrophil cyto-
plasmic antibody-associated systemic vasculitis (AASV) (  18  ). JEM VOL. 205, July 7, 2008  1575
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Fig. 2 A  ).   The probes used on our array do not diff  erentiate 
between   FCGR3A   and   B  , but the expression pattern was 
consistent with absent   FCGR3B  . Flow cytometric analysis 
of the proband confi  rmed the lack of neutrophil cell surface 
Fc    RIIIb. Surface expression of Fc    RIIIb showed a clear tri-
modal pattern, consistent with Mendelian inheritance of an 
  FCGR3B  -null allele (  Fig. 2, B and C  ).   Fig. 2 C   shows a fl  ow 
cytometry plot for six family members labeled A  –  F showing the 
clear diff  erences in protein expression in the proband (A), her 
son, daughter, and brother with a single   FCGR3B  -null allele 
(B  –  D), and her husband and other brother (E and F) with two 
copies of   FCGR3B  .   FCGR3B   CN, as measured by quantita-
tive real-time PCR (qPCR), was lower in individuals B, C, 
and D than in individuals E and F (  Fig. 2 D  ).   FCGR3B   CN, 
as determined by qPCR, correlated with CN inferred from 
protein expression and heredity in family members (  Fig. 2 E  ). 
Further PCR analysis demonstrated that the genetic defect 
spared   FCGR3A   and   FCGR2B   and included   HSPA7   and 
the   FCGR2C   (  Fig. 2 F  ), consistent with previous observa-
tions in   FCGR3B  -null individuals (  25  ), although the CN 
variable region at this locus may show more complexity and 
variability in the general population. The genomic defect 
seen in this family was confi  rmed at the protein level; Fc    RI, 
Fc    RIIa, and Fc    RIIb were expressed on the cell surface 
of neutrophils, and Fc    RIIIa was expressed on monocytes 
(Fig. S4). CD59 was also present on neutrophils (excluding 
a general defect in GPI linkage as an explanation for reduced 
Fc    RIIIb;   Fig. 2 G  ). 
  We next analyzed neutrophils from family members 
with known   FCGR3B   CN to defi  ne its function. Superoxide 
anion production in response to several stimuli thought to 
be FcR independent, such as formyl-Met-Leu-Phe (fMLP), 
granulocyte-macrophage colony-stimulating factor (GM-CSF), 
and PMA, was not aff  ected by   FCGR3B   CN (  Fig. 3 A  ).   
To assess the ability of neutrophils to localize to immune com-
plexes, we analyzed the adherence of neutrophils fl  owed over 
surfaces coated with IgG, and demonstrated that adherence 
was proportional to   FCGR3B   CN (  Fig. 3 B  ). Immune com-
plex adherence to, and uptake by, neutrophils also increased 
with increasing CN (  Fig. 3, C and D  ). Reduced neutrophil 
function was not associated with reduced expression of other 
Fc    Rs; indeed, a slight increase in expression of Fc    RI and 
Fc    RIIa was observed in the Fc    RIIIb-defi  cient proband 
(Fig. S4). There was also a correlation between CN, as mea-
sured by qPCR, and soluble circulating Fc    RIIIb (  Fig. 3 E  ), 
which is released upon neutrophil activation (  15  ). 
    FCGR3B   CN correlates with protein expression and function 
in the normal population 
  We wished to determine if this association of   FCGR3B   CN 
with expression and function was seen in normal populations. 
We used qPCR to determine CN in 33 healthy individuals. 
Although we have shown in the family, and by comparison 
with the HapMap data, that   FCGR3B   CN is proportional to 
results from the qPCR assay, defi  nitive assignment of CN in 
threshold, compared with the number of cycles required for 
amplifi  cation of a control gene that does not show CNV; in 
this case,   CD36  .   FCGR3B  /  CD36   ratios as determined by 
this assay are not integers, as might have been expected, but 
form a near continuous distribution, which is a well recog-
nized feature of CN assays (  7, 8  ). We therefore compared 
cases and controls on each plate using a Student  ’  s   t   test, and 
then performed a Student  ’  s   t   test stratifi  ed by the two plates 
of samples. In total, 171 samples from Caucasian patients with 
SLE were compared with 176 ethnically matched control 
samples. We found lower CN was signifi  cantly associated with 
SLE in Caucasians (P = 0.027;   Fig. 1 A   and Fig. S1, available 
at http://www.jem.org/cgi/content/full/jem.20072413/DC1), 
but such an association was not seen in a Chinese SLE cohort 
from Hong Kong, comprising 159 cases and 150 controls 
(  Fig. 1 B   and Fig. S1).   This lack of association held true when 
the patients with lupus nephritis (  n   = 57) were analyzed in-
dependently (Fig. S2).   FCGR3B   CN distributions did not 
diff  er signifi  cantly between the control Caucasian and Chinese 
populations (Fig. S3). SLE is more common, more severe, of 
earlier onset, and has some distinct clinical features in East 
Asians compared with Europeans. These clinical diff  erences 
are independent of environment and likely to be genetically 
determined, thus it is to be expected that SLE will have dif-
ferent genetic infl  uences in diff  erent ethnic groups (  29  ); e.g., 
a transmembrane polymorphism in neighboring   FCGR2B   is 
associated with SLE in Asian (  30  ), but not European or African-
American, populations (  31  ). 
  Correlation between   FCGR3B   CN, protein expression, 
and function in a family 
  To defi  ne the function of Fc    RIIIb, and whether this func-
tion was infl  uenced by CNV, we fi  rst studied CN, expression, 
and function using a family with   FCGR3B   defi  ciency. As 
part of a comprehensive program of expression profi  ling of 
purifi  ed cell subsets in autoimmune disease, we identifi  ed 
an individual with SLE who had no   FCGR3   mRNA in 
neutrophils, but normal levels of   FCGR3   mRNA in mono-
cytes (Supplemental clinical information, available at http://
    Figure 1.         Association of low   FCGR3B   CN with UK, but not Hong 
Kong, SLE  . qPCR was used to determine   FCGR3B/CD36   ratios in normal 
controls and patients with SLE. In each case, results from 1 (representa-
tive of 2) qPCR plate are shown (all of the raw data are shown in Fig. S1, 
A and B). The horizontal bar indicates the mean. The P values shown indi-
cate comparison of all cases and controls using a stratifi  ed Student  ’  s   t  
test. (A) UK SLE patients,   n   = 171; UK controls,   n   = 176. (B) Hong Kong SLE 
patients,   n   = 159; Hong Kong controls,   n   =  150.   1576   FCGR3B   COPY NUMBER, SYSTEMIC LUPUS ERYTHEMATOSUS, AND VASCULITIS   | Willcocks et al. 
    Figure 2.         Correlation between   FCGR3B   CN and protein expression in a family  . (A) Array of gene expression patterns (mRNA) for FCGR genes in 
neutrophils and monocytes of individuals with SLE. Each row corresponds to a gene, and each column to an individual. Red indicates increased expression 
compared with PBMC reference; green represents reduced expression. The patient (A in panel B) with no   FCGR3B   expression is marked with an asterisk. 
(B) Family tree of the   FCGR3B -defi  cient patient A, showing Mendelian inheritance of the null allele. CN was determined using fl  ow cytometry. (C) Flow 
cytometry of neutrophils stained for PE-labeled antibody to Fc    RIIIb demonstrates reduced surface expression on cells from individuals B, C, and D (with 
a single   FCGR3B   copy) compared with individuals E and F, who have two   FCGR3B   copies. Geometric mean fl  uorescences were 7, 2,265, 2,241, 2,303, 
3,484, and 3,730 for A  –  F, respectively. (D) Gene dosage of   FCGR3B   relative to   CD36  , determined by qPCR, for patient A (no   FCGR3B  ), her daughter patient 
B, her son patient C, and her brother patient D (with a single   FCGR3B   copy), as well as for her husband patient E and her other brother patient F (with two 
copies of   FCGR3B  ). (E) qPCR was performed on DNA from all family members whose Fc    RIIIb expression had been determined by fl  ow cytometry. Gene 
dosages of   FCGR3B   relative to   CD36   (by qPCR) were signifi  cantly higher in those individuals who by fl  ow cytometry were shown to have greater surface 
expression of Fc    RIIIb. The horizontal bar indicates the mean. (F) Delineation of the extent of the deletion in patient A and family members B, C, and E 
using PCR;   FCGR3B ,   HSPA7  , and   FCGR2C   are absent. (G) A similar delineation using fl  ow cytometry in patient A. Fc    RIIa (neutrophils), Fc   RIIb  (neutro-
phils shown, confi  rmed on B cells, and not depicted) and Fc    RIIIa (NK cells) are present (isotype control shaded gray), but Fc    RIIIb (neutrophils) is absent. 
CD59 is expressed on neutrophils, thus GPI linkage is intact. JEM VOL. 205, July 7, 2008  1577
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dividual and her family and in normal volunteers with diff  erent 
CN, show clearly that reduced expression of Fc    RIIIb is 
  associated with reduced immune complex uptake and with 
reduced neutrophil adhesion to immune complex  –  bearing 
surfaces. We have also confi  rmed a genetic association between 
SLE and low CN. Our data would suggest that the mecha-
nism underlying this association is a failure of neutrophil traf-
fi  cking to infl  ammatory lesions and reduced ability to ingest 
immune complexes once there, thereby reducing immune 
complex clearance and predisposing to SLE. Hence   “  normal  ”   
levels of Fc    RIIIb (both neutrophil-surface and soluble) may 
be important in protection against SLE. Our results thus pro-
vide a mechanism explaining the genetic association of low 
  FCGR3B   CN and SLE. 
  Association of high   FCGR3B   CN with AASV in three 
UK cohorts 
  Unlike SLE, AASV is not associated with immune complex 
deposition. Rather, whereas neutrophils are not thought to play 
a major role in infl  ammatory damage in SLE, it is clear that Fc 
receptor-mediated neutrophil activation is important in AASV 
pathogenesis (  33  ). Thus, it might be expected that increased 
  FCGR3B   CN would be associated with AASV. We therefore 
analyzed   FCGR3B   CN in 286 ethnically matched controls 
and 556 patients derived from the following 3 independent 
the general population is diffi   cult (  7, 8  ). We therefore se-
lected individuals whose   FCGR3B  /  CD36   ratios were clearly 
low (lowest fi  ve values), intermediate, or high (highest fi  ve 
values), and using neutrophils from these individuals showed 
that CNV was associated with Fc    RIIIb expression (  Fig. 4, 
A and B,   and Fig. S5, available at http://www.jem.org/cgi/
content/full/jem.20072413/DC1).   As in the index family, 
there was a clear correlation between CN and neutrophil 
  adherence to immunoglobulin-coated surfaces under fl  ow 
conditions, with high CN individuals having four times the 
rate of adherence of those with low   FCGR3B   CN (  Fig. 4, 
C and D,   and Supplemental videos). Once adherence had oc-
curred, spreading of the neutrophils on the surface appeared 
independent of   FCGR3B   CN (Table S1). Immune complex 
uptake was also reduced in those with low CN (  Fig. 4 E  ), 
whether or not complement was present (not depicted). As 
in the family, levels of circulating soluble Fc    RIIIb corre-
lated with   FCGR3B   CN as determined by qPCR (Fig. S6 A). 
Thus, the association between   FCGR3B   CN, protein ex-
pression, and function seen in the index family could be 
extrapolated to the population at large. 
  SLE has long been known to be associated with defects in 
immune complex clearance, and SLE lesions are invariably 
associated with immune complex deposition (  32  ). The func-
tional data presented here, in both an Fc    RIIIb-defi  cient in-
    Figure 3.         Correlation between   FCGR3B   CN and neutrophil function in a family.   (A) No signifi  cant differences in superoxide anion production 
between family members with 0, 1, and 2 copies of   FCGR3B   were observed after Fc receptor  –  independent stimulation with GM-CSF, fMLP, or PMA (two-
way ANOVA, P = ns). Mean and SEM from two independent experiments are shown. (B) Quantifi  cation of neutrophil adhesion to IgG-coated glass slides 
after 4 min of fl  ow at a shear stress of 0.1 Pa in the   FCGR3B  -null individual and her single-copy daughter relative to the three CN control. (C) Percentages 
of neutrophils with bound, antibody-opsonized, Alexafl  uor-labeled ovalbumin after 10 min at 4  °  C, for family members with 0, 1, and 2 copies of   FCGR3B . 
Mean and SEM are shown for triplicate repeats of one experiment that is representative of two. (D) Percentages of neutrophils with bound and internal-
ized, antibody-opsonized, Alexafl  uor-labeled ovalbumin after 10 min at 37  °  C, for family members with 0, 1, and 2 copies of   FCGR3B  . Mean and SEM are 
shown for triplicate repeats of one experiment that is representative of two (the same experiment is shown in C). P values in C and D refer to one-way 
ANOVA with a post test for linear trend. (E) sFc    RIIIb in serum, as measured by ELISA, increases with   FCGR3B   CN in patient A  ’  s family (letters correspond 
to individuals shown in   Fig. 1 B  ).     1578   FCGR3B   COPY NUMBER, SYSTEMIC LUPUS ERYTHEMATOSUS, AND VASCULITIS   | Willcocks et al. 
culating Fc    RIIIb in patients with SLE and AASV at both 
disease onset and after therapy (patients described in the Sup-
plemental clinical information and Table S2, available at 
http://www.jem.org/cgi/content/full/jem.20072413/DC1). 
In the 43 patients with AASV, soluble Fc    RIIIb levels at 
diagnosis correlated with   FCGR3B/CD36   ratio, and levels 
were signifi  cantly higher than both controls and the 15 lupus 
patients (Fig. S6, B and C). 
  An early report suggested that low, rather than high,   
FCGR3B   CN is associated with AASV (  26  ). The most likely 
reason for this is that that study compared groups after CN 
assignation, despite the continuous nature of the data. This is 
known to risk producing misleading results (  7, 8  ), is likely to 
explain the variation in CN distribution observed between 
ethnically similar control groups (  26  ), and may be part of the 
reason why low   FCGR3B   CN was found to be associated 
with lupus nephritis alone in one study (  5  ), but not others 
([  26  ] and this study). To ensure the accuracy of our data, we 
AASV cohorts: a UK cohort with biopsy-proven, ANCA-
  associated renal vasculitis (cohort 1,   n   = 347), an independent 
ANCA-associated vasculitis cohort (cohort 2,   n   = 136), and 
a vasculitis cohort from Birmingham, UK (cohort 3,   n   = 73). 
Further details of these cohorts are described in the online 
supplemental material. Cases and controls were plated to-
gether and compared using a Student  ’  s   t   test as described above 
and in the Materials and methods. No association between 
disease and low CN was seen in any of the three cohorts; in 
fact, AASV was associated with high CN when cases from all 
cohorts were compared with controls (P = 10      8   calculated us-
ing a Student  ’  s   t   test stratifi  ed by plate of samples;   Fig. 5, A  –  C,   
and Fig. S1).   To substantiate the observation that   FCGR3B   
CN distribution diff  ered between SLE and AASV, we com-
pared samples from both groups directly on a single plate 
(  Fig. 5 D  ). Patients with SLE showed a signifi  cantly lower 
mean   FCGR3B/CD36   ratio than patients with AASV (P = 
0.0028;   Fig. 5 D  ). We then measured levels of soluble cir-
    Figure 4.           FCGR3B   CN is proportional to gene expression and function in the normal population.   Surface expression of Fc   RIIIb  increases 
with increasing   FCGR3B   CN. (A) Flow cytometry plot of neutrophils stained with PE-labeled anti-Fc    RIIIb in one experiment that is representative of 
three. (B) Expression of Fc    RIIIb (geometric mean fl  uorescence normalized in three separate experiments to the mean of intermediate CN individuals) 
correlates with gene dosage of   FCGR3B  . P value refers to one-way ANOVA with a post test for linear trend. The horizontal bar indicates the mean. 
(C) Neutrophil adhesion to IgG-coated glass slides after 4 min of fl  ow at a shear stress of 0.1 Pa in an individual with low   FCGR3B   compared  with 
that of an individual with high   FCGR3B  . Bar, 20   μ  m. (D) Neutrophil adhesion to bound IgG under fl  ow conditions increases with   FCGR3B   CN  (after 
4 min of fl  ow at a shear stress of 0.1 Pa) in two experiments, which were pooled. P value refers to one-way ANOVA with a post test for linear trend. 
The horizontal bar indicates the mean. (E) Uptake of immune complexes in individuals with low, intermediate, or high   FCGR3B.   Percentages of neutro-
phils positive for FL4 after 10 min incubation with antibody-opsonized, Alexafl  uor-labeled ovalbumin at 37  °  C are greater in individuals with more 
  FCGR3B  . Mean and SEM are shown for three to six individuals per group from two experiments. P value from nonparametric one way ANOVA 
(Kruskal-Wallis test).     JEM VOL. 205, July 7, 2008  1579
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These associations will need to be investigated to determine 
the mechanism by which CNV contributes to disease. In this 
study, we use a family with   FCGR3B   defi  ciency to demon-
strate not only the physiological function of the receptor, but 
also the eff  ect of   FCGR3B   CNV on protein expression and 
function. By extending these studies into the general popula-
tion, we show for the fi  rst time the association between CNV, 
expression, and function of a disease-related gene, providing 
a functional explanation for the genetic association between 
low   FCGR3B   CN and SLE. 
    MATERIALS AND METHODS   
    FCGR3B   CN determination 
  qPCR.       FCGR3B   CN was measured using qPCR modifi  ed from that 
  previously described (  5  ), with the exception that   FCGR3B   values were 
normalized to   CD36   rather than   FOXP2  . In brief, 10   μ  l PCR reactions, 
using 2.5 ng of genomic DNA as template, were performed using SYBR 
green (Quantifast; QIAGEN) and an ABI 7900HT real-time PCR system 
with a 384-well module (ABI). Cycling conditions were 95  °  C for 5 min, 
and then 40 cycles of 95  °  C for 10 s, followed by 60  °  C for 30 s. All sam-
ples were measured in duplicate, and for each sample the diff  erence be-
tween replicate Ct values was determined. The mean diff  erence across 
all samples was then determined, and any samples with a diff  erence in val-
ues exceeding the mean plus two standard deviations were removed from 
the dataset. 
  The number of cycles required for amplifi  cation of   FCGR3B   to reach 
threshold (the Ct value) was then compared with the number of cycles 
  required for amplifi  cation of   CD36  , a gene that does not show CNV. 
The ratio of   FCGR3B   Ct/  CD36   Ct is therefore a measure of   FCGR3B   
CN. Two diffi   culties posed by the assay had to be circumvented as follows. 
First, we found that the   FCGR3B  /  CD36   ratios were not integers, as might 
be expected from the principle of CNV. This is a well recognized problem 
with CN assays (  7  ). Indeed, when we downloaded array comparative hy-
bridization data for probes encompassing the   FCGR3B   locus (from 270 
HapMap individuals), we saw a spread of log intensities similar to the pat-
tern seen using the qPCR assay (Fig. S7, available at http://www.jem.org/
cgi/content/full/jem.20072413/DC1). We obtained DNA from 14 of these 
individuals from the Coriell Institute (Camden, NJ), and found a close cor-
relation between aCGH data and qPCR ratios of   FCGR3B  /  CD36   (Fig. S8 B). 
The second potential problem we found was that, although the distribu-
tion of   FCGR3B  /  CD36   ratios for a given set of samples is remarkably con-
stant upon repeat measurement, the absolute values may vary on repetition 
(Fig. S8 B). We therefore plated control and diseased samples together. We 
compared cases and controls on each plate using a Student  ’  s   t   test, and then 
performed a Student  ’  s   t   test stratifi  ed by both plates of   samples. We were 
able to do this because the means of the   FCGR3B  /  CD36   ratios for SLE 
cases were lower than control means on both plates of samples used, and the 
means of the AASV samples were greater than controls on all seven plates 
assayed. Fig. S1 shows the raw data for all plates of SLE and AASV cases 
and controls. 
  Microarray analysis 
  Blood samples were obtained from 15 SLE patients with active disease and 
10 age- and sex-matched normal controls. Neutrophils and monocytes were 
isolated by magnetic cell sorting, total RNA was extracted, and microarray 
hybridizations were performed as previously described (  36  ), except that 
pooled targets were resuspended in 60   μ  l hybridization buff  er and hybridized 
on a SlideBooster hybridization station (Advalytix). All samples were hybrid-
ized to custom spotted oligonucleotide microarrays in duplicate, using a 
dye-swap strategy, against a common reference RNA prepared from pooled 
PBMC RNA obtained from seven normal controls. Raw image data were 
extracted using Koadarray v2.4 (Koada Technology); probes were listed 
used three independent cohorts (including one overlapping 
with [  26  ]) and larger numbers of patients, and we compared 
raw values using a stratifi  ed Student  ’  s   t   test rather than arbitrary 
  “  binning  ”   (as discussed in the Materials and methods). In addi-
tion, we correlated results with a family of known   FCGR3B   
CN and with DNA from individuals with CN determined 
independently from the HapMap data. Finally, we correlated 
our assay with Fc    RIIIb surface expression and function 
(  Fig. 4, A and B,   and Fig. S5), and with soluble Fc    RIIIb 
titers (Fig. S6). We are therefore confi  dent AASV is associated 
with increased   FCGR3B   CN. Nonetheless, all of the results 
in this fi  eld will need to be reassessed as more sophisticated 
CN assays are developed in the future. 
  The associations of high   FCGR3B   CN with AASV and 
low CN with SLE is consistent with what is known of the 
pathophysiology of these diseases. In AASV, unlike SLE, in-
fl  ammatory lesions are characterized by neutrophil infi  ltration, 
but not immune complex deposition (  33  ). ANCA is thought 
to mediate its pathogenic eff  ect by activating neutrophils in an 
Fc     receptor  –  dependent fashion (  34  ) and should therefore be 
exacerbated by increased   FCGR3B   CN. In addition, AASV is 
associated with   FCGR3B*1,   the isoform of Fc    RIIIb that 
confers increased phagocytosis, (  16, 18  ), whereas SLE is asso-
ciated with   FCGR3B*2,   which is associated with reduced 
phagocytosis (  16, 30, 35  ), providing further evidence that the 
receptor plays a diff  erent role in each disease. 
  CNV is an important cause of genetic variation in popu-
lations, and has recently been implicated in complex disease 
causation. The known associations with disease will increase 
as whole-genome association studies are analyzed for CNV. 
    Figure 5.         Association of high   FCGR3B   CN with AASV.   qPCR  was 
used to determine   FCGR3B/CD36   ratios in normal controls and cohorts 
of patients with AASV (cohorts described in Supplemental materials and 
methods). In each case, results from one representative qPCR plate are 
shown (all of the raw data are shown in Fig. S1 C). The horizontal bar 
indicates the mean. P values shown for each cohort indicate com-
parison of all cases and controls using a stratified Student  ’  s   t   test. 
(A  –  C) AASV versus control in three independent UK cohorts. (D) Single plate 
of SLE and AASV, compared using a Student  ’  s   t   test.  Supplemental 
materials and methods and Fig. S1 C are available at http://www.jem
.org/cgi/content/full/jem.20072413/DC1.   1580   FCGR3B   COPY NUMBER, SYSTEMIC LUPUS ERYTHEMATOSUS, AND VASCULITIS   | Willcocks et al. 
individual plate, an unpaired   t   test with Welch  ’  s correction was performed. 
All statistical tests were performed using either the Prism software (Graph-
Pad) or the R statistical system (www.r-project.org). P values   <  0.05 were 
considered signifi   cant. Further details regarding individual statistical tests 
performed can be found in the appropriate fi  gure legend. 
  Research ethics 
  This study was approved by the Cambridge Local Research Ethics Commit-
tee, the Leeds East Research Ethics Committee, the Oxford Multi-center 
Research Ethics Committee, and the Institutional Review Board of the 
University of Hong Kong/Hospital Authority. 
  Online supplemental material 
  The Supplemental materials and methods contain additional methodol-
ogy. The Supplemental clinical information contains clinical details for 
the   FCGR3B  -defi  cient individual and her family, as well as clinical infor-
mation on the SLE patients whose microarray data are shown in   Fig. 1  , 
and the AASV patients whose soluble Fc    RIIIb levels are shown in Fig. S6. 
Table S1 shows the percentage of cells that undergo spreading after adhe  sion 
is unrelated to   FCGR3B   CN. Table S2 is a summary of clinical features of 
SLE and AASV patients whose soluble Fc    RIIIb levels are shown in Fig. S6. 
Table S3 shows gene-specifi  c primer sequences used for   Fig. 1 E  . Fig. S1 
shows qPCR raw data for all plates of samples analyzed. Fig. S2 shows that, 
in a Chinese population from Hong Kong,   FCGR3B   CN does not diff  er 
signifi  cantly in patients with SLE nephritis compared with healthy controls. 
Fig. S3 shows that   FCGR3B   CN does not diff  er signifi  cantly in healthy 
Chinese individuals from Hong Kong compared with UK Caucasians. Fig. S4 
Cell surface expression by fl  ow cytometry of Fc    RIIa (A), Fc    RI (B) and 
Fc    RIIb (C) on neutrophils and Fc    RIIIa (D) on monocytes of patient A 
(in red) and two individuals known to have   FCGR3B  . Fig. S5 shows that 
the fi  nding that   FCGR3B   CN is proportional to gene expression is repro-
ducible. Fig. S6 shows correlation of   FCGR3B   CN and soluble Fc    RIIIb. 
Fig. S7 shows array comparative genomic hybridization data across the 
  FCGR3B   locus on chromosome 1q22-23. Fig. S8 shows the   FCGR3B  /
  CD36   ratio detected by qPCR correlates with aCGH data and is reproducible. 
Videos 1  –  4 show neutrophil adhesion and spreading to IgG-coated glass slides 
during 4 min of fl  ow at a shear stress of 0.1 Pa. Videos are shown for repre-
sentative individuals with low, intermediate, and high   FCGR3B   CN. The 
online version of this article is available at http://www.jem.org/cgi/content/
full/jem.20072413/DC1. 
  We thank Dr. Tom Freeman for contribution to array development; Drs. Kevin Harris, 
David Jayne, and Afzal Chaudhry for clinical input; and Dr. Chaudhry for statistical 
advice. We are grateful to all the patients involved in the study, but in particular for 
the generous contribution to this research made by our Fc   RIIIb-defi  cient patient 
and her family. We also acknowledge Dr. Dawn L. Cooper  ’  s contribution to the fl  ow 
cytometry data. 
  K.G.C. Smith is supported by a Wellcome Trust Clinician Research Leave 
Award and is a Lister Prize Fellow, L.C. Willcocks is a Medical Research Council 
Clinical Training Fellow, M.R. Clatworthy is a Wellcome Trust Intermediate 
Fellow, and additional support was provided by the Medical Research Council 
(MRC), Kidney Research UK (KRUK), the Genzyme Renal Innovations Programme, 
and the national Institute for Health Research Cambridge Biomedical Research 
Centre. A.W. Morgan and J.I. Robinson are supported by the Arthritis 
Research Campaign. We acknowledge the MRC/KRUK National DNA Bank for 
Glomerulonephritis and Caroline Savage, Lavanya Kamesh, and Lorraine Harper, 
for contributions to DNA cohorts. MRC/KRUK DNA bank sample management 
was undertaken by the UK DNA Banking Archive Network, funded by the 
MRC at the Centre for Integrated Genomic Medical Research, University 
of Manchester. HapMap DNA was supplied by the Coriell Institute for 
Medical Research. 
  The authors have no confl  icting fi  nancial interests. 
Submitted:   13 November 2007 
Accepted:   19 May 2008 
as present if they had a spot confi  dence value   >  0.3 in at least 1 channel. 
Background subtracted intensity values for all probes considered present 
were imported into GeneSpring v7.2 and Lowess normalized before further 
analysis. Microarray data have been deposited in ArrayExpress with the ac-
cession no.   E-TABM-463  . 
  Genomic PCR 
  DNA was extracted from peripheral whole blood using the QIAamp Mini 
blood kit (QIAGEN) as per the manufacturers  ’   protocol. For gene-specifi  c 
PCRs, optimum specifi  city was obtained by performing annealing tempera-
ture gradients on each primer pair. All PCRs were performed in 1  ×   Pro-
mega PCR buff  er (including 1.5 mM MgCl  2  ) with Taq polymerase. Gene 
specifi  city was confi  rmed by sequencing of all amplicons. Primer sequences 
are shown in Table S3. 
  Functional assays 
  Immune complex adhesion and uptake assays.     Whole blood was di-
luted in PBS with Ca  2+  /Mg  2+   to give a neutrophil concentration of 10  6   
cells/ml. To make the immune complexes, Alexafl  uor-labeled ovalbumin 
(Invitrogen) was opsonized with rabbit polyclonal antiovalbumin antibody 
(Sigma-Aldrich) at 37  °  C for 1 h. Neutrophils were incubated with ovalbu-
min, in opsonized or nonopsonized form, for 10 min, at either 37  °  C or 4  °  C. 
Erythrocytes were then lysed with BD FACS Lysing Solution. The percent-
age of neutrophils positive for Alexafl  uor-labeled ovalbumin was assessed by 
fl  ow cytometry, as described previously. 
  Neutrophil adhesion assay.     Neutrophils were isolated from whole blood 
by two-step gradient centrifugation as previously described (  37  ). The adhe-
sion of fl  owing neutrophils to IgG-coated microslides and the subsequent 
behavior of the adherent cells was measured as previously described (  37  ). 
  Superoxide assay.     Respiratory burst activity was determined by means of 
the superoxide dismutase  –  inhibitable reduction of cytochrome   c  , as previ-
ously described (  38  ). 
  Flow cytometry 
  The antibodies used in this study were: anti-Fc    RIIIb (clone 3G8; BD Bio-
sciences), anti-Fc    RIIa (clone FLI8.26; BD Biosciences), anti-Fc    RIIb 
(MacroGenics) (  39  ), anti-Fc    RI (clone 10.1; Invitrogen), anti-CD56 (clone 
MEM88; Invitrogen), and anti-CD59 (clone Mem-43; Invitrogen). Isotype 
controls were IgG2a (clone G155-178), IgG1     (clones MOPC-21), and 
IgG2b     (clone MPC-11). 100-  μ  l aliquots of whole blood were incubated 
with 10   μ  l Fc block (Miltenyi Biotec) and 10   μ  l of appropriate labeled anti-
bodies for 20 min at room temperature. Erythrocytes were lysed using BD 
FACS Lysing Solution, and surface expression assessed by fl  ow cytometry on 
a FACSCalibur (BD Biosciences). Data were analyzed using FlowJo software 
(Tree Star, Inc.). 
  sFc    RIIIb ELISA 
  Microtitre plates (MaxiSorp; Nunc) were coated with 0.3   μ  g/ml anti-CD16 
mAb (clone DJ130c; Dako) overnight at 4  °  C. Plates were washed three 
times with PBS/0.05% Tween-20 and blocked for 2 h at room temperature 
with PBS/10% FCS. Serum samples were diluted in PBS, added to the plate, 
and incubated for 4 h at room temperature. Plates were washed and incu-
bated for 2 h at room temperature with biotinylated anti-CD16 mAb (clone 
3G8). After a further wash, plates were revealed with streptavidin-HRP 
  followed by TMB (Sigma-Aldrich) according to manufacturer  ’  s instructions. 
Absorbance at 450 nm was measured after 15 min on an OPTImax tunable 
microplate reader. 
  Statistical analyses 
  The statistical signifi  cance of data characterizing the function of Fc    RIIIb 
was determined using either a one- or two-way analysis of variance test. 
When comparing   FCGR3B/CD36   ratios between cases and controls on an JEM VOL. 205, July 7, 2008  1581
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